loading page

COVID-19 infection thrombosis due to hemagluttination of antibodies and COVID-19 antigens bound to erythrocytes
  • Kevin Roe
Kevin Roe
Retired
Author Profile

Abstract

A new pathogenic virus, COVID-19, appeared in 2019, in Wuhan, China, typically causing fever, cough, diarrhea and fatigue and significant mortality. COVID-19 has also shown about 80% genetic similarity to the Severe Acute Respiratory Symptom (SARS) virus, which is already known to be derived from a bat virus. Arterial thrombosis and venous thrombosis, variously attributed to long term patient immobilizations, inflammation, autoimmune reactions or endothelial cell damage to the blood vessels, have also been reported for COVID-19 infections. However, there is another explanation for thrombosis (blood clots) in many patients infected with COVID-19.

Peer review status:Published

30 Apr 2020Submitted to Transboundary and Emerging Diseases
30 Apr 2020Submission Checks Completed
30 Apr 2020Assigned to Editor
02 May 2020Review(s) Completed, Editorial Evaluation Pending
02 May 2020Reviewer(s) Assigned
03 May 2020Editorial Decision: Revise Major
04 May 20201st Revision Received
04 May 2020Assigned to Editor
04 May 2020Submission Checks Completed
05 May 2020Reviewer(s) Assigned
12 May 2020Review(s) Completed, Editorial Evaluation Pending
12 May 2020Editorial Decision: Revise Minor
13 May 20202nd Revision Received
13 May 2020Assigned to Editor
13 May 2020Submission Checks Completed
14 May 2020Review(s) Completed, Editorial Evaluation Pending
14 May 2020Editorial Decision: Accept
Published in Transboundary and Emerging Diseases. 21 May 2020. 10.1111/tbed.13634